Cargando…
Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer
BACKGROUND: Compounds that can act as agonists for toll-like receptors (TLRs) may be promising candidates for the development of drugs against infectious diseases and cancer. The present study aimed to characterize the immunomodulatory effects of P-MAPA on TLRs in vitro and in vivo, as well as to in...
Autores principales: | Fávaro, Wagner J, Nunes, Odilon S, Seiva, Fabio RF, Nunes, Iseu S, Woolhiser, Lisa K, Durán, Nelson, Lenaerts, Anne J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408364/ https://www.ncbi.nlm.nih.gov/pubmed/22709446 http://dx.doi.org/10.1186/1750-9378-7-14 |
Ejemplares similares
-
Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier
por: Garcia, Patrick Vianna, et al.
Publicado: (2016) -
Potential therapeutic strategies for non - muscle invasive bladder cancer based on association of intravesical immunotherapy with P-MAPA and systemic administration of cisplatin and doxorubicin
por: Dias, Queila Cristina, et al.
Publicado: (2016) -
P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling
por: de Almeida Chuffa, Luiz Gustavo, et al.
Publicado: (2018) -
P-MAPA and Interleukin-12 Reduce Cell Migration/Invasion and Attenuate the Toll-Like Receptor-Mediated Inflammatory Response in Ovarian Cancer SKOV-3 Cells: A Preliminary Study
por: Lupi, Luiz Antonio, et al.
Publicado: (2019) -
P-MAPA and
IL-12 Differentially Regulate Proteins
Associated with Ovarian Cancer Progression: A Proteomic Study
por: Júnior, Luiz Antonio Lupi, et al.
Publicado: (2019)